{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T19:23:23Z","timestamp":1784402603629,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Infantile hemangiomas (IH) are common benign tumors of infancy. Most IH involute, either spontaneously, or secondary to pharmacological treatment with systemic propranolol. Propranolol treatment mostly leads to regression of hemangiomas with satisfactory aesthetic results, but unfortunately not in all cases. To assess the safety and efficacy of long pulsed Nd:YAG 1064\u00a0nm laser in treating patients with residual infantile hemangioma after systemic propranolol treatment. This is an open-label prospective cohort study. 30 patients with focal residual IH that had sub-optimal responses to systemic propranolol treatment were enrolled in the study. The patients were treated with 1 to 3 sessions with long pulsed Nd:YAG 1064\u00a0nm laser. The maximal response of the IH was assessed using a 4-point scale evaluation scale system. Of the 30 patients enrolled, 18 patients exhibited a great response (&gt;\u200976% improvement), 10 patients had a good response (&gt;\u200951\u201375% improvement), while only 2 patients showed a moderate response (&lt;\u200950% improvement) to the treatment. No patients had an unsatisfactory response. No serious side effects were observed, and only minor side effects were reported. The treatment with long pulsed Nd:YAG 1064\u00a0nm laser for residual IH, which were resistant to systemic propranolol treatment, is safe and effective. Thus, we suggest its use as a second-line treatment for patients with sub-optimal aesthetic results following systemic propranolol.<\/jats:p>","DOI":"10.1038\/s41598-023-33870-0","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T18:06:11Z","timestamp":1683569171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nd:YAG 1064-nm laser for residual infantile hemangioma after propranolol treatment"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-2807","authenticated-orcid":false,"given":"Z.","family":"Khamaysi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zaaroura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Avitan-Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"33870_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1542\/peds.58.2.218","volume":"58","author":"AH Jacobs","year":"1976","unstructured":"Jacobs, A. H. & Walton, R. G. The incidence of birthmarks in the neonate. Pediatrics 58, 218\u2013222 (1976).","journal-title":"Pediatrics"},{"key":"33870_CR2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1001\/archderm.1953.01540030065006","volume":"67","author":"AG Pratt","year":"1953","unstructured":"Pratt, A. G. Birthmarks in infants. AMA Arch. Derm. Syphilol. 67, 302\u2013305 (1953).","journal-title":"AMA Arch. Derm. Syphilol."},{"key":"33870_CR3","first-page":"8","volume":"86","author":"AH Jacobs","year":"1957","unstructured":"Jacobs, A. H. Strawberry hemangiomas; the natural history of the untreated lesion. Calif. Med. 86, 8\u201310 (1957).","journal-title":"Calif. Med."},{"key":"33870_CR4","first-page":"273","volume":"341","author":"D Ba","year":"1999","unstructured":"Ba, D., Nb, E. & Ij, F. Hemangiomas in children. N. Engl. J. Med. 341, 273\u2013274 (1999).","journal-title":"N. Engl. J. Med."},{"key":"33870_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1542\/peds.85.4.491","volume":"85","author":"O Enjolras","year":"1990","unstructured":"Enjolras, O., Riche, M. C., Merland, J. J. & Escande, J. P. Management of alarming hemangiomas in infancy: A review of 25 cases. Pediatrics 85, 491\u2013498 (1990).","journal-title":"Pediatrics"},{"key":"33870_CR6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1651-2227.1955.tb04151.x","volume":"44","author":"K Holmdahl","year":"1955","unstructured":"Holmdahl, K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatr. 44, 370\u2013379 (1955).","journal-title":"Acta Paediatr."},{"key":"33870_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/archderm.1960.01580050009002","volume":"82","author":"RE Bowers","year":"1960","unstructured":"Bowers, R. E., Graham, E. A. & Tomlinson, K. M. The natural history of the strawberry nevus. Arch. Dermatol. 82, 667\u2013680 (1960).","journal-title":"Arch. Dermatol."},{"key":"33870_CR8","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(00)70042-0","volume":"231","author":"WA Lister","year":"1938","unstructured":"Lister, W. A. The natural history of strawberry N\u00e6vi. Lancet 231, 1429\u20131434 (1938).","journal-title":"Lancet"},{"key":"33870_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1525-1470.2011.01644.x","volume":"28","author":"L Bagazgoitia","year":"2011","unstructured":"Bagazgoitia, L., Hern\u00e1ndez-Mart\u00edn, \u00c1. & Torrelo, A. Recurrence of infantile hemangiomas treated with propranolol. Pediatr. Dermatol. 28, 658\u2013662 (2011).","journal-title":"Pediatr. Dermatol."},{"key":"33870_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1063\/1.1753928","volume":"4","author":"JE Geusic","year":"2004","unstructured":"Geusic, J. E., Marcos, H. M. & van Uitert, L. G. Laser oscillations in Nd-doped yttrium aluminum, yttrium gallium and gadolinium garnets. Appl. Phys. Lett. 4, 182 (2004).","journal-title":"Appl. Phys. Lett."},{"key":"33870_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-3-2","volume":"3","author":"I Vlachakis","year":"2003","unstructured":"Vlachakis, I., Gardikis, S., Michailoudi, E. & Charissis, G. Treatment of hemangiomas in children using a Nd:YAG laser in conjunction with ice cooling of the epidermis: Techniques and results. BMC Pediatr. 3, 1\u20136 (2003).","journal-title":"BMC Pediatr."},{"key":"33870_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1610-0387.2005.05723.x","volume":"3","author":"H Ulrich","year":"2005","unstructured":"Ulrich, H., B\u00e4umler, W., Hohenleutner, U. & Landthaler, M. Neodymium-YAG Laser for hemangiomas and vascular malformations\u2014long term results. J. Dtsch. Dermatol. Ges 3, 436\u2013440 (2005).","journal-title":"J. Dtsch. Dermatol. Ges"},{"key":"33870_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/lsm.22455","volume":"48","author":"S Chinnadurai","year":"2016","unstructured":"Chinnadurai, S., Sathe, N. A. & Surawicz, T. Laser treatment of infantile hemangioma: A systematic review. Lasers Surg. Med. 48, 221\u2013233 (2016).","journal-title":"Lasers Surg. Med."},{"key":"33870_CR14","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1055\/s-0039-1700481","volume":"41","author":"U Patil","year":"2008","unstructured":"Patil, U. & Dhami, L. Overview of lasers. Indian J. Plast. Surg. 41, S101 (2008).","journal-title":"Indian J. Plast. Surg."},{"key":"33870_CR15","first-page":"473","volume":"12","author":"KM Kaune","year":"2014","unstructured":"Kaune, K. M. et al. Combination therapy of infantile hemangiomas with pulsed dye laser and Nd:YAG laser is effective and safe. J. Dtsch. Dermatol. Ges. 12, 473\u2013478 (2014).","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"33870_CR16","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1039\/c9pp00079h","volume":"18","author":"M Zutt","year":"2019","unstructured":"Zutt, M. Laser treatment of vascular dermatological diseases using a pulsed dye laser (595 nm) in combination with a Neodym:YAG-laser (1064 nm). Photochem. Photobiol. Sci. 18, 1660\u20131668 (2019).","journal-title":"Photochem. Photobiol. Sci."},{"key":"33870_CR17","doi-asserted-by":"publisher","first-page":"e20151754","DOI":"10.1542\/peds.2015-1754","volume":"137","author":"SD Shah","year":"2016","unstructured":"Shah, S. D. et al. Rebound growth of infantile hemangiomas after propranolol therapy. Pediatrics 137, e20151754 (2016).","journal-title":"Pediatrics"},{"key":"33870_CR18","doi-asserted-by":"publisher","first-page":"e13331","DOI":"10.1111\/dth.13331","volume":"33","author":"K Kridin","year":"2020","unstructured":"Kridin, K., Pam, N., Bergman, R. & Khamaysi, Z. Oral propranolol administration is effective for infantile hemangioma in late infancy: A retrospective cohort study. Dermatol. Ther. 33, e13331 (2020).","journal-title":"Dermatol. Ther."},{"key":"33870_CR19","doi-asserted-by":"publisher","first-page":"e14936","DOI":"10.1111\/dth.14936","volume":"34","author":"N Pam","year":"2021","unstructured":"Pam, N., Kridin, K. & Khamaysi, Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatol. Ther. 34, e14936 (2021).","journal-title":"Dermatol. Ther."},{"key":"33870_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze, C. et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N. Engl. J. Med. 372, 735\u2013746 (2015).","journal-title":"N. Engl. J. Med."},{"key":"33870_CR21","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/bjd.12432","volume":"169","author":"CK Ahogo","year":"2013","unstructured":"Ahogo, C. K. et al. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol. Br. J. Dermatol. 169, 1252\u20131256 (2013).","journal-title":"Br. J. Dermatol."},{"key":"33870_CR22","doi-asserted-by":"publisher","first-page":"e173947","DOI":"10.1542\/peds.2012-3828","volume":"131","author":"H Chan","year":"2013","unstructured":"Chan, H., McKay, C., Adams, S. & Wargon, O. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds. Pediatrics 131, e173947 (2013).","journal-title":"Pediatrics"},{"key":"33870_CR23","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2147\/DDDT.S134808","volume":"11","author":"L Zhang","year":"2017","unstructured":"Zhang, L., Wu, H. W., Yuan, W. & Zheng, J. W. Propranolol therapy for infantile hemangioma: Our experience. Drug Des. Dev. Ther. 11, 1401\u20131408 (2017).","journal-title":"Drug Des. Dev. Ther."},{"key":"33870_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","volume":"390","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2017","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze, C., Harper, J. I. & Hoeger, P. H. Infantile haemangioma. Lancet 390, 85\u201394 (2017).","journal-title":"Lancet"},{"key":"33870_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/pde.12089","volume":"30","author":"AL Marqueling","year":"2013","unstructured":"Marqueling, A. L., Oza, V., Frieden, I. J. & Puttgen, K. B. Propranolol and infantile hemangiomas four years later: A systematic review. Pediatr. Dermatol. 30, 182\u2013191 (2013).","journal-title":"Pediatr. Dermatol."},{"key":"33870_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1468-3083.2011.04102.x","volume":"25","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2011","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze, C., Prey, S. & Ezzedine, K. Infantile haemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J. Eur. Acad. Dermatol. Venereol. 25, 1245\u20131253 (2011).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"33870_CR27","first-page":"37","volume":"7","author":"S Admani","year":"2014","unstructured":"Admani, S., Feldstein, S., Gonzalez, E. M. & Friedlander, S. F. Beta blockers: An innovation in the treatment of infantile hemangiomas. J. Clin. Aesthet. Dermatol. 7, 37 (2014).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"33870_CR28","first-page":"1","volume":"9780857292810","author":"K Nouri","year":"2012","unstructured":"Nouri, K. Lasers in dermatology and medicine. Lasers Dermatol. Med. 9780857292810, 1\u2013626 (2012).","journal-title":"Lasers Dermatol. Med."},{"key":"33870_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1610-0387.2008.06657.x","volume":"6","author":"R Grantzow","year":"2008","unstructured":"Grantzow, R. et al. Hemangiomas in infancy and childhood. S 2k Guideline of the German Society of Dermatology with the working group Pediatric Dermatology together with the German Society for Pediatric Surgery and the German Society for Pediatric Medicine. J. Dtsch. Dermatol. Ges. 6, 324\u2013329 (2008).","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"33870_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.2015.13969","volume":"315","author":"S Prey","year":"2016","unstructured":"Prey, S. et al. Safety of propranolol therapy for severe infantile hemangioma. JAMA 315, 413\u2013415 (2016).","journal-title":"JAMA"},{"key":"33870_CR31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ad.2012.12.010","volume":"104","author":"J Alc\u00e1ntara-Gonz\u00e1lez","year":"2013","unstructured":"Alc\u00e1ntara-Gonz\u00e1lez, J. et al. Infantile hemangiomas treated by sequential application of pulsed dye laser and Nd:YAG laser radiation: A retrospective study. Actas Dermosifiliogr. 104, 504\u2013511 (2013).","journal-title":"Actas Dermosifiliogr."},{"key":"33870_CR32","first-page":"310","volume":"9","author":"AM Saafan","year":"2010","unstructured":"Saafan, A. M. & Salah, M. M. Using pulsed dual-wavelength 595 and 1064 nm is more effective in the management of hemangiomas. J. Drugs Dermatol. 9, 310\u2013314 (2010).","journal-title":"J. Drugs Dermatol."},{"key":"33870_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/00006534-199808000-00029","volume":"102","author":"CJ Chang","year":"1998","unstructured":"Chang, C. J., Anvari, B. & Stuart-Nelson, J. Cryogen spray cooling for spatially selective photocoagulation of hemangiomas: A new methodology with preliminary clinical reports. Plast. Reconstr. Surg. 102, 459\u2013463 (1998).","journal-title":"Plast. Reconstr. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33870-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33870-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33870-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T18:09:55Z","timestamp":1683569395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33870-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33870"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33870-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"assertion":[{"value":"14 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7474"}}